Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03316872
Title Study of Pembrolizumab and Radiotherapy in Liver Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Health Network, Toronto
Indications

hepatocellular carcinoma

Therapies

Pembrolizumab

Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.